Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma: an ongoing multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERING-Melanoma

Schadendorf, Dirk and Richtig, Erika and Loquai, Carmen and Forschner, Andrea and Gutzmer, Ralf and Haferkamp, Sebastian and Utikal, Jochen and Hassel, Jessica Cecile and Meier, Friedegund and Debus, Dirk and Fluck, Michael and Goeppner, Daniela and Kehrer, Helmut and Dummer, Reinhard and von Moos, Roger and Thompson, Jan and Gengenbacher, Laura and Michielin, Olivier and Hoeller, Christoph (2022) Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma: an ongoing multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERING-Melanoma. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Poster)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Petra Gürster
Date Deposited: 11 Oct 2023 05:35
Last Modified: 11 Oct 2023 05:35
URI: https://pred.uni-regensburg.de/id/eprint/58547

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.